Scientists hunt for blood clues to predict liver cancer treatment success
NCT ID NCT04459468
Summary
This study aimed to find new markers in the blood that could help predict how well standard liver cancer treatments work. Researchers took blood samples from 17 patients before and after they received their normal treatments, like TACE or ablation. The goal was to see if certain proteins in the blood could forecast a patient's survival or if the cancer would progress.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATOCELLULAR CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
UT Southwestern Medical Center
Dallas, Texas, 75390, United States
Conditions
Explore the condition pages connected to this study.